The Heavyweight New Product Ademetionine 1,4-butanedisulfonate for Injection was Approved
On June 27, 2014, the Ademetionine 1,4-butanedisulfonate for Injection that developed and researched mainly by our company was approved by the State Food and Drug Administration with the Approval No.: Medicine H20143203.
This kind of medicine is widely used to treat intrahepatic cholestasis of pregnancy as well as the cholestasis before and after liver cirrhosis. At present, the authoritative market investigation shows a good development prospect for this product. The approval of ademetionine is no doubt a good news for the hepatopath and must has a bright market prospect.